Details of the Drug
General Information of Drug (ID: DM5ONA9)
| Drug Name |
Cysteine Hydrochloride
|
||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
DL-Cysteine hydrochloride; 10318-18-0; 2-amino-3-mercaptopropanoic acid hydrochloride; CYSTEINE HYDROCHLORIDE; H-DL-Cys-OH.HCl; (+-)-Cysteine hydrochloride; DL-CYSTEINE HCL; CYSTEINE, HYDROCHLORIDE, DL-; EINECS 233-698-2; DL-Cysteine hydrochloride hydrate; NSC8746; DL-Cysteine hydrochloride anhydrous; MFCD00064552; 2-amino-3-sulfanylpropanoic acid hydrochloride; C-9675; DL-Cysteine hydrochloride, 95%, anhydrous; AK-73021; L-Cysteine, hydrochloride (1:1); Cysteine chlorohydrate; H-DL-Cys-OH Cl; L-Cystein-hydrochloride
|
||||||||||||||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||||||||||||||
| 3D MOL is unavailable | 2D MOL | ||||||||||||||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||||||||||||||
| Drug ADMET Endpoint Profile (DAE)NEW | Click to Jump to the Detailed DAE Information of This Drug | ||||||||||||||||||||||||||||||||||
| Repurposed Drugs (RPD) | Click to Jump to the Detailed RPD Information of This Drug | ||||||||||||||||||||||||||||||||||

